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	 Figure 1. 1α,25-dihydroxycholecalciferol 
[1,25-(OH)2D3] also known as Vitamin D3. 







Vitamin D is the only vitamin that is free. It can be easily obtained from exposure to sunlight and 
yet more than 60% of Americans are Vitamin D deficient (Ginde et al., 2009; Bones, Vitamin D, 
and Calcium, n.d). The significance of Vitamin D can’t be emphasized enough and is often 
overlooked. Some its profound effects are apparent in the prevention of various diseases such as 
cancer, multiple sclerosis, and cardiovascular disease et cetera. Many lives can be spared each 
year just by taking Vitamin D. From cancer alone, 23,000 deaths can be attributed each year to a 
lack of Vitamin D (Grant, 2002; Reichrath, 2008). Vitamin D deficiency in America is an 
epidemic that needs to be addressed. 
 Vitamins:  
Vitamins are required for the well being of the human body, in essence in achieving homeostasis. 
Vitamins are organic substances (coenzymes) that can’t be synthesized by the human body. 
Vitamins are divided into two discrete categories: water-soluble and lipid-soluble vitamins. 
Water soluble vitamins can be eliminated easily from the body in the form of urine and sweat. 
On the other hand, an excess intake of lipid soluble vitamins can be fatal. They can’t be easily 
excreted as a waste, due to their hydrophobic properties. Vitamin D is one such lipid soluble 
vitamin that is stored in adipose tissue. 
Vitamin D3 Background 
Vitamin D is a steroid hormone despite it being classified as a vitamin. The molecular structure 
of Vitamin D closely resembles typical steroid hormones, which have the same cyclopentanoper-
hydrophenanthrene root carbon ring structure. This suggests that Vitamin D reacts similarly to 
other steroid hormones. There are various forms of Vitamin D, but the naturally occurring form 
is cholecalciferol, also known as Vitamin D3.   The primarily and most abundant source of 
Vitamin D is obtained during the presence of sunlight. It can also be naturally obtained from 
several food sources, however, in minute amounts. 
BiochemistryA cholesterol molecule, 7-Dehydrocholesterol functions as a precursor to 
Vitamin D. The highest concentrations are found in the epidermis, particularly the stratum basale 
and stratum spinosum layers. In conjunction with sunlight, in the form of Ultra-violet B 
radiation, cholecalciferol is synthesized. The most effective wavelength is found between the 
range of 270-290 nm. This absorption excites the double bonds, allowing the B-ring to open, 
thereby making it into a more flexible structure.  Once produced, cholecalciferol (D3) the inactive 
form of Vitamin D3 is then transported to the liver by the 
plasma transport protein, Vitamin D–binding protein 
(DBP) or also known as transcalciferin (TC). In the 
endoplasmic reticulum of hepatocytes, cholecalciferol is 
hydroxylated at the Carbon-25 position to yield 25-
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hydroxycholecalciferol (Calcidiol) by the enzyme 25-hydroxylase. It is then successively 
transported by DBP to the proximal tubules of the kidney where it is catalyzed by the enzyme 
1α-hydroxylase. The hydroxyl is placed on Carbon 1 or 24 to yield the following, 1α,25-
dihydroxycholecalciferol [1,25-(OH)2D3]   and 24R,25-dihydroxyvitamin D3 [24,25(OH)2D3] 
respectively (Dixon, 1982). Finally, by a means of diffusion (Hollis et al., 2008), DBP transports 
both steroids to their target tissues, where 1α,25-dihydroxycholecalciferol or also known as 
calcitriol, is considered to be the hormonally active form of Vitamin D3 (Figure 1). The inactive 
form 24, 25(OH)2D3 , is chemically degraded and eventually excreted as either calcitroic acid or 
as 23-carboxyl derivatives. In comparison to its inactive isomer 24,25(OH)2D3, the affinity of 
calcitriol to Vitamin D3 receptor sites is over 1000 times more than to its isomer. (Norman, 1990; 
1998; MacDonald & Sutton, 2003)  
Vitamin D3 similarly to other steroid hormones, binds to intracellular ligand-dependent 
transcription receptors. Being hydrophobic it is easily able to penetrate the phospholipid 
membrane of target cells.  Once in the cytosol of the cell, Vitamin D3 binds to a receptor protein 
known as the Vitamin D receptor (VDR), which prompts a cascade of macromolecular 
interactions leading to the transcription of certain genes. Promoted by Vitamin D3 the Vitamin D 
receptor forms a heterodimer complex with the retinoid-X receptor (RXR), a category of class II 
nuclear receptors. Class II receptors are known as transcription factors which regulate the 
expression of specific genes .In contrast to class I receptors, class II receptors are found in the 
nucleus of the cell. With the correspondence of Vitamin D3 the active receptor protein complex 
enters the nucleus and initiates a series of molecular interactions, where the activation and 
suppression of specific modification of genes occurs. The specific sequences of genes that it 
seeks are known as the Vitamin D-responsive elements. Finally the transcription of these genes 
is executed and an mRNA strand is produced, where it is translated into specific proteins by 
ribosomes (Norman, 1998; Campbell & Reece, 2001; Holick, 2004). 
Regulation: Parathyroid Hormone 
Parathyroid hormone (PTH) is necessarily mentioned here on the basis that it plays a crucial role 
in the regulation of Vitamin D3. The rate limiting step of Vitamin D3 production occurs in the 
kidney and is accomplished by the enzyme 1α-hydroxylase.  The parathyroid hormone plays an 
active role in directly either inhibiting or by the activation of the enzyme 1α-hydroxylase, which 
in turn produces l,25(OH)2D3. Also to be noted the half-life of Vitamin D3 is only approximately 
3-4 hours. Due to its short half life, its production is tightly regulated as a means of conserving it, 
where PTH essentially serves as this control point in the production of Vitamin D3 (Bowen, n.d.). 
Receptor Sites: 
Calcitriol targets a wide range of tissues. Until recently VDR sites for l,25(OH)2D3 were only 
known to be located on bones, intestines and in the kidneys. New research formulates that VDR 
receptors are localized in cancer cell lines, the pituitary gland, the skin, hematopoietic cells, 
leukocytes including T and B lymphocytes, reproductive organs, ß-islet cells of the pancreas, and 
nerve cells. This suggests the additional roles and involvement of Vitamin D3 ,  in the functioning 




Vitamin D3 has been recognized for maintaining adequate levels of calcium in the serum. 
Additionally, it has been associated with keeping bones strong, as we know drinking milk as a 
source of Vitamin D3, has been highly encouraged over the past years by the statement “Got 
Milk”. Vitamin D3 has been evident in preventing rickets in children and osteoporosis 
(osteomalacia) in adults. Moreover, recent evidence has established that Vitamin D3 has 
extraordinary properties that go beyond strong bones, to such an extent that it has been reputed 
as a preventive medicine. It is apparent that it functions and is highly involved in the 
immunological system. It has been proven to prevent an extensive range of diseases including, 
multiple sclerosis, cardiovascular disease, diabetes, and most forms of cancer (Vitamin D 
Science, n.d.; Zittermann, 2003). 
Calcium  
Calcium (Ca2+), a key element required for the human survival. A minor drop in calcium levels 
can be fatal and lead to cardiac arrest.  Calcium is associated with maintaining and keeping the 
strength and rigidity of bones. Additionally, it is also responsible for the propagation of action 
potentials across nerve synapses. Release of neurotransmitters (exocytosis) into the synaptic cleft 
is prompted by calcium ions, which consecutively are transmitted along and received by adjacent 
dendritic cells in the post synaptic region. In addition, calcium plays a pivotal role in muscle 
contraction such as of the skeletal and cardiac muscles (Tortora, Grabowski, & Roesch, 1996, p. 
125). 
One of the essential attributions of Vitamin D3 is for promoting calcium absorption.  One way 
this is achieved is by the absorption of calcium from the lumen of the small intestine, primarily 
in the duodenum and jejunum. Calcitriol activates specific gene factors in DNA that translate into 
carrier proteins known as Vitamin D-dependent calcium binding proteins .These act as a vector 
for transporting proteins across the small intestine and into the blood. The most commonly 
known of these calcium transporters is calbindin (Norman, 1990; Tortora et al., 1996, pp. 525-
527). Calcium absorption also occurs in the distal convoluted tubule (DCT) of the nephron. In 
concert with parathyroid hormone, production of 1,25(OH)2D3 results in changes in gene 
expression that eventually results in the re reabsorption of Ca2+in the tubule (Lajeunesse & 
Brunette, 1991). 
A drop in serum calcium levels (normal reference range is 8.5 - 10.5 mg/dL), induces the 
parathyroid gland to secrete parathyroid hormone (PTH) in an attempt to restore normal calcium 
levels back to normal. PTH brings about the release of calcium from the bones by osteoclast 
formation, thereby reducing bone density. Excess PTH can lead to fragile bones, a condition 
known as osteoporosis. However, when Vitamin D is present, calcium is obtained by the 
alternative means such discussed above, conserving bone density by leaving bones intact and 
strong. Additionally, Vitamin D has been shown to interact with PTH, activating osteoclasts and 
subsequently the release of calcium. However, Vitamin D stimulates intestinal calcium uptake 
and excess calcium is restored to bones by osteoblast formation. Therefore, this accounts for a 
net gain of calcium, strengthening and maintaining the bone matrix (Tortora et al., 1996). 
Cellular Differentiation 
All cells originate from pluripotent stem cells, as they divide and mature they reach a climax 
state, where differentiation isn’t possible anymore. In contrast to differentiated cells, immature 
cells proliferate rapidly, as evident in embryos and infants. Alternatively, aging accounts for the 
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lack of stem cells, brought about by terminal differentiation (Cell Differentiation, n.d; Oberley et 
al., 1980). Being that cancer cells are similar to embryonic tissues, and are relatively 
undifferentiated, they have a high growth rate potential (Sell, 2004). Furthermore, stem cells are 
present in malignant tumors, this evidently substantiates their similarity in their differentiation 
state and growth pattern (Farkas et al., 2009; Kopper & Hajdú, 2004; Tumor Stem Cells, n.d).   
Vitamin D3 via gene expression factors induces the differentiation of osteoblasts. Osteoblasts, 
derived from osteoprogenitor cells, secrete collagen and other essential organic components 
required in bone formation and maintenance. Additionally, many genes are directly involved in 
the cell cycle and influence proliferation, differentiation, and apoptosis in distinctively every 
cell. This speculates that Vitamin D3 deficiency can consequently result in a low degree or lack of 
cellular differentiation (Kadakia et al., 2010; Samuel & Sitrin, 2008; Tortora et al., 1996, p. 144). 
Immunology  
Vitamin D3 plays an exceptional role in the immune system. Vitamin D deficiency is an 
unrecognized epidemic among both children and adults in the United States. Vitamin D 
deficiency not only accounts for rickets among children and osteoporosis among adults but is 
also highly associated with increased risks for Multiple Sclerosis (MS), malignant cancers, 
cardiovascular disease, and both types of diabetes mellitus but primarily type 1 (Holick, 2004). 
Multiple Sclerosis 
Multiple Sclerosis, also known as MS, is a chronic autoimmune disease that affects the central 
nervous system (CNS). The CNS consists of the brain and the spinal cord. On a cellular level, 
neurons continuously transmit and receive signals, each being a minute, yet a necessary part of 
the intricate CNS orchestration, that culminate in the actions, sensations, thoughts and emotions 
that comprise the human experience. Normally, the path over which a nerve signal or action 
potential travel is protected by an insulation of fibrous material known as the myelin sheath or 
white matter. This is essential for efficient nerve conduction and propagation.  In MS, the myelin 
sheath is eroded, which diminishes the ability of neurons to properly transmit signals.  
It is believed that the loss of myelin is the result of mistaken attack of white blood cells. In MS 
something goes awry; white blood cells infiltrate the CNS, cross the blood brain barrier, seek out 
and destroy the myelin.  As an ongoing inflammation of nerve tissue occurs, nerve signals are 
disrupted, leading to an array of symptoms; ranging from numbness or tingling to blindness and 
paralysis (Multiple Sclerosis, n.d.). 
In MS an unknown trigger activates helper T cells (CD-4), which correspondingly recognize 
myelin as an antigen. Once activated, helper T cells reproduce and release cytokines such as 
interleukin-2. Subsequently B cells and cytotoxic T cells (CD-8) become stimulated, enabling 
them to cross the blood brain barrier. Once in the cerebrospinal fluid (CSF), B-cells produce 
immunoglobulins or antibodies that bind to myelin and oligodendracytes (cells of CNS that 




Figure 2. Epidemiology of Multiple Sclerosis: World map showing 
that risk (incidence) for MS increases with greater distance from the 
equator. Source: Multiple Sclerosis International Federation. (Atlas of 
MS Database, n.d). 
Figure 3. Pooled analysis of observed 
births in people with multiple sclerosis. 
Source: British Medical Journal. (Willer 
et al., 2005) 
Currently about 350,000 people in the United States and over 2 million people worldwide are 
affected by MS 
(Dangond, n.d.).  
Statistics have revealed 
that there is a higher 
incidence of MS in 
regions where inadequate 
sunlight exists. As a 
trend, the risk of 
developing multiple 
sclerosis usually increases 
with the distance from the 
equator (Figure 2). 
Astonishingly, regions 
near the equator are risk 
free or have a 0 MS risk 
coincidence.  The risk of 
acquiring MS increases 
dramatically with latitude 
and is inversely related to 
sunlight. For instance, in 
Canada 240 out of 100,000 people have MS, compared to a mere of 9 in Mexico (Atlas of MS 
Database, n.d.). In the United States, the prevalence rate of MS below the 37th parallel is 57 to 
78 out of 100,000 people. On the other hand, above the 37th parallel, the prevalence rate of MS 
is 110 to 140 per 100,000 people, approximately twice the rate as below the 37th parallel. An 
insufficient level of Vitamin D transpires under low sunlight conditions, which make one more 
susceptible to MS (Nursing Home Care, n.d.). 
In a case conducted study, a group of researchers at the Harvard School of Public Health 
accessed serum samples of more than 7 million military personnel. Two hundred and fifty seven 
of them were diagnosed with MS and had blood samples taken prior to diagnoses. Each had their 
serum level compared to at least two other control subjects that were disease free. They were 
matched on the basis of common characteristics such as age, serum collection date etc. They 
were then ranked into five groups based on their Vitamin D levels. Predictability, those with MS 
fell disproportionately into the lowest-ranking groups.   Those in the highest compared to the 
lowest-ranking group, had a lower risk of developing MS by a staggering rate of 62 percent. 
(Munger et al., 2006) 
Based on a study, pregnant women are encouraged to obtain 
Vitamin D. In this study the mothers of approximately 
35,000 nurses provided information regarding their diet 
during pregnancy. After a span of 16 years, 199 out of these 
nurses developed MS. It was concluded that the mothers that 
consumed Vitamin D during pregnancy, gave birth to 
daughters with a 45 percent less risk of developing MS in 
years to come (Langer-Gould et al., 2010). Additionally, 
babies born in northern countries during the month of 
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Figure 4. Annual mortality rates for 
breast carcinoma in white females (1970-
1994) versus DNA-weighted ultraviolet 
(UV) radiation for July 1992. Source: 
American Cancer Society (Grant, 2002) 
 
November have shown a decreased risk of developing multiple sclerosis later on in life (Figure 
3). This study was based on 42,000 people and those that were born in November had a 19% 
decreased risk of developing multiple sclerosis over those that were born in May. Mothers 
pregnant during sunny months have higher levels of Vitamin D in their serum, which apparently 
is gets passed on to their developing baby (Willer et al., 2005). 
MS patients often experience and/or are prone to bone fractures. MS is also associated with a 
high frequency of osteoporosis. The bone mass density (BMD) of the lumbar spine and femoral 
neck was found to be one to twofold lower in women with MS against controls. Low circulating 
levels of Vitamin D that were found in MS patients, can account for this direct relationship. 
(Siokaa et al., 2009; Van der Mei et al., 2007; Correale et al., 2009; Nieves et al., 1994) 
.Additionally, MS patients with a high Vitamin D level has shown a lesser relapse rate than 
controls.  A dosage of 15 ng per mL, which is equivalent to 2000 international units (IU) has 
been shown to cut the relapse rate by half (Correale et al., 2009; Mowry et al., 2010). 
Cancer 
In between 1970 to 1994, cancer mortality rates in the US were approximately twice as high in 
the northeast compared with the southwest. An 
examination of 506 regions found a close inverse 
relationship between cancer mortality rates and 
levels of sunlight in the form of UV-B radiation. 
Annually, 21,700 premature deaths result due to a 
lack of Vitamin D.  These results were obtained by 
comparing UV-B data in various regions and by 
using regression analysis based methods (Figure 4). 
This study surveyed and concluded that Vitamin D 
is associated with the prevention of most forms of 
cancers, including breast, colon, ovarian, prostate, 
lung, pancreatic, stomach, non-Hodgkin lymphoma, et 
cetera (Grant, 2002; Reichrath, 2008). 
A four year randomized study conducted by the 
Creighton University School of Medicine revealed that 
Vitamin D can reduce cancer risks by a dramatic 60 to 77 percent. The subjects were 1,179 
randomly selected healthy women over the age of 55. Participants were free of known cancers 
for a minimum of ten years prior to entering the study.  Each group was either given 1,400-1,500 
mg supplemental calcium, 1,400-1,500 mg supplemental calcium plus 1,100 IU of Vitamin D3 
(nearly three times the Recommended Daily Amount) or just placebos. Over the course of four 
years there was no statistically significant difference in cancer incidence between participants 
taking placebos and those just taking calcium supplements. However, those in the Vitamin 
D3/Calcium group demonstrated a remarkable 60 percent cancer risk reduction, than to the 
placebo group alone.  
On the premise that some women entered the study with undiagnosed cancers, the first year was 
eliminated from the study. During the last three years, the results became even more apparent in 
signifying the effects of Vitamin D3 on Cancer. In those three years alone, the calcium/Vitamin 
D3 group exhibited a startling 77 percent cancer-risk reduction. These results were based on the 
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notion that calcium intervention had no significant difference in cancer reduction and were 
primarily due to the positive effects of Vitamin D3. The significance of this study was that it was 
population based and subjects were randomly selected. Additionally, the study had a low dropout 
rate of less than 3.5 percent, due to the high level of treatment adherence, which applauds to the 
positive effects of Vitamin D3. This provides strong evidence that Vitamin D3 is the most 
effective medicine against cancer, far more than any other drug (Lappe, 2007). 
There has been some controversy, however, in the role of Vitamin D3 in the prevention of 
cancer. In a study conducted between 1995 and 2005, the Women's Health Initiative (WHI) 
gathered over 36 thousand participants, making it the largest randomized clinical trial of calcium 
and Vitamin D ever done. The subjects were divided into two groups and were administered 
twice daily either, 500 mg of calcium plus 200 IU Vitamin D3 or just placebo alone. Participants 
were required to make clinical visits annually and answer a series of questions every six months, 
in order to determine the effects of the pills. Over an average span of seven years, a total of 322 
women were diagnosed with invasive colorectal cancer. In comparison to participants who took 
the active Ca-D supplements with those who took placebo pills, there was no substantial 
difference in the rate of colorectal cancer diagnoses, prompting evidence that Vitamin D3 may 
not play a role in cancer prevention (Wactawski-Wende et al., 2006). 
However there are many flaws in this study, considering scientists’ estimate that it may take at 
least 10 to 20 years for colorectal cancer to develop and the study was limited to an average of 7 
years. Additionally, the WHI based its report on colorectal cancer incidence but failed to account 
for the many other predominant forms of cancers. The highly significant inverse relationship 
between Vitamin D3 and the risk incident for all cancers was reported in the Creighton study.  
Nevertheless, it was observed in the WHI study that the participants with lowest quartile of 
serum had an overall colorectal cancer incidence that was 253 percent of the incidence in the 
highest quartile. Furthermore, a much lower dose of Vitamin D3 was used in the study than in 
the Creighton study. A dose of 400 IU was administered, which is inadequate in promoting the 
health benefits of Vitamin D3 to the full potential. It is now generally recommended that 1000 IU 
of Vitamin D3 daily is necessary to attain proper levels in order to achieve optimal prevention of 
cancer and other crucial benefits such as calcium absorption and bone strength (Holick et al., 
2003). Finally, all the subjects in the study had Vitamin D insufficiency prior to the start of the 
trial and also during the trial based on the criterion given above (Holick, 2006). 
The best source of evidence that significantly demonstrates that a higher dose of 1000 IU of 
Vitamin D3 is advisable for preventing colorectal cancer, besides for other cancers, is based on a 
Quantitative meta-analysis pool of data from an extensive range of studies that were conducted  
between January 1966 and December 2004. The five studies that were surveyed contained serum 
collections from a wide variety of healthy volunteers who were closely monitored for periods 
ranging from two to twenty five years. There were a total of 1,448 total participants, 535 in the 
pooled analysis and 913 controls. The researches established that 1000 IU of Vitamin D3 is 
associated with a 50 percent, or half of a risk reduction, of developing colorectal cancer, rather 
than the 400 IU of D3 that was seen in the WHI study. The results were obtained by dividing the 
pooled results into quintiles with median values. Odds ratios were calculated by quintile, with the 
lowest as the reference group. Based on the odds for each quintile of the pooled data, a dose 
response curve was plotted. Data were abstracted and analyzed in 2006. It has also concluded 
that public awareness is needed to increase the Vitamin D3 intake of to 1000 IU per day (Holick 
et al., 2007; Holick et al., 2005).  
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Figure 5. MC-26 tumor size in vitamin D–deficient (solid 
line) vs. vitamin D–sufficient (dashed line) mice.Source: 
Journal of Nutrition (Tangpricha et al., 2005) 
Figure 6. The cell cycle. 
Source: University of 
Arizona. (The Cell 
Cycle, n.d.). 
 
Figure 7. Model illustrating CDK regulation. Source: 
Harvard Medical School (Van den Heuvel, 2005). 
 
To validate the effects of Vitamin D3 deficiency and cancer, mice with lacking VDR receptor 
sites were assessed. Vitamin D effects are mediated through VDR receptors, a ligand-dependent 
transcription factor.  In comparison to normal wild type mice, the VDR knockout mice exhibited 
accelerated growth and heavier mammary glands. This supported the hypothesis that Vitamin D3 
inhibits proliferation and induces differentiation.  Additionally, this study demonstrated that 
VDR absent mice were more prone and sensitive to mammary tumors that were induced due to a 
disruption of Vitamin D3 (Welsh, 2004). To further determine the effects of Vitamin D and 
cancer proliferation, two groups of mice were fed different diets. The first group was fed a 
Vitamin D deficient diet for three months. 
The other was fed the same diet but with 
supplemental Vitamin D for the same 
duration. The mice were then injected with 
MC-26, a colon cancer cell line. The tumors 
were measured daily for an interval of 
twenty days.  The result: the Vitamin D 
sufficient mice had forty percent smaller 
tumors than the Vitamin D deficient mice. In 
the Vitamin D sufficient mice the expression 
of the mRNA for the VDR and 1α-
hydroxylase were measured and found to be 
37- and 6-fold higher, respectively, in 
comparison to the Vitamin D absent mice. These 
results support the notion that Vitamin D3 
inhibits the proliferation of cancer (Tangpricha 
et al., 2005). 
Cell Cycle 
Human development and maintenance requires billions of rounds of the cell cycle. The cell cycle 
is split into two stages, Interphase and Mitosis, respectively. Interphase 
accounts for approximately 95 percent of the cell cycle, making it the 
prominent stage in regards to cellular regulation. It consists of a sequence 
of three distinct phases in the order of the G1, S, and G2 (Figure 6). Mitosis 
is defined as the M phase. Depending on environmental and developmental 
signals, cells in the G1 phase may temporarily or permanently cease 
division and enter into an arrested phase known as the G0 resting phase 
.Highly differentiated cells, such as, nerve cells exist in the G0 state 
(Tortora et al., 1996, p. 80) .A mishap in the cell cycle is believed to be an attribution for cancer. 
Simultaneously, Vitamin D is believed to be one of the crucial components 
responsible for cellular regulation and thus preventing cellular 
abnormalities that contribute for cancer. 
 In transition to consecutive 
phases, throughout the cell cycle there are several 
regulatory checkpoints. A group of protein kinase 
molecules known as Cyclin-dependent kinases 
(CDK’s) trigger the transition of subsequent phases 
in the cell cycle (Figure 7). CDK’s are in an active 
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state when bound to Cyclin proteins and by direct phosphorylation. Cyclin molecules are 
degraded as they progress through the cell cycle; in respect to time their concentration varies in a 
cyclical fashion. This ensures that cells only proceed up to the subsequent cycle. CDK’s are kept 
in an inactive state through association with CDK-inhibitory proteins (CKIs) and by Wee1, 
inhibitory phosphorylation molecules. Activation requires ubiquitin-dependent proteolysis of the 
CKI, phosphorylation of the CDK by a CDK-activating kinase (CAK), and removal of the 
inhibitory phosphates by Cdc25 (cell division cycle) phosphatase. 
Interphase consists of several regulatory checkpoints. They ensure proper cell development, 
DNA replication and other critical processes that enable a cell to be error free.  The G1 
checkpoint (G1through S phase) is regulated by CDK-2, -4, and CDK6 proteins, which proper 
entry into the S phase. The G2 checkpoint (G2 to mitosis) is regulated by the CDK-1 protein, 
which promote M-phase progression. Identical DNA allows the cells to proceed through these 
checkpoints. However, the unexpected can occur, damaged DNA are often recognized and 
repaired. Nevertheless, unsuccessful repair attempts can result in cellular aptosis. Families of 
CDK kinase inhibiters (CKI) include classes of p21, p27, and p57 proteins. Their function is to 
inhibit a broad range of CDK’s, including CDK-1, 2, 4, and CDK-6. In breast cancer cells, 
Vitamin D3 impeded proliferation by preventing entry into the S-phase. Vitamin D3 was 
identified to up-regulate  p21 inhibiters through analogues. One such analogue is EB1089, a 
derivative of Vitamin D3 with modified side chains. This targets and inactivates CDK-2 
complexes, thereby terminating DNA synthesis and cell replication (Jeffrey et al., 1995; Liu et 
al., & Freedman, 1996; Jensen et al., 2001). 
Sunscreens and Sunlight 
People use sunscreen as a protective measure from the sun’s rays. According to evident studies, 
sunscreens may do more harm than good. Sunscreens block Vitamin D production, which can 
contribute to far greater cancer deaths than it prevents (Dennis, Freedman, & VanBeek, 2003). 
Each year less than 1500 people die from skin related cancers while each day, 1500 people die 
from other cancers (Cancer Facts & Figures, n.d.; Skin Cancer Facts, n.d.). Sunscreens with an 
SPF of 8 or greater block both UVA and UVB rays (Hughes & Talbott, 2007). UVB rays are 
necessary to synthesize Vitamin D in the skin. Sun block may prevent skin cancer but at the 
same time, can be attributed to other major forms of cancer that are far more fatal.  
Sunlight is often associated with promoting skin cancer but it has been demonstrated to the 
contrary in a San Diego study. During 1974 to 1984, there were 176 confirmed cases of 
melanoma that were identified in active-duty white male personnel enlisted in the US Navy.  
Occupations were grouped in three categories based on sunlight exposure, as indoor, outdoor or a 
combination of indoor/outdoor. Compared to the U.S. civilian population, those working indoor 
had a higher melanoma occurrence of 10.6 per 100,000 people. Those who worked in 
occupations that required spending time both indoors and outdoors had the lowest rate, of 7.0 per 
100,000 people. Additionally, incidence rates of melanoma were higher on the trunk than on 
more common sunlight exposed areas, such as the head and arms. This establishes that moderate 
amounts of sunlight can prevent melanoma rather than cause it (Garland et al., 1990). 
According to the CDC melanoma has been rising sharply for the last several decades ("Notice to 
Readers:," 2000). Yet, concurrently, as year’s progress, less time is spent outdoors. In the 
early1900’s more than 75% of the North American population worked outdoors compared to 
only 10% by the 1970’s (Genius, 2006). This trend illustrates an inverse relationship between 
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sunlight and melanoma. Furthermore, the greatest increase of melanoma occurred after the 
introduction of sunscreens. Death rates in the US between the 1950’s and 1990’s doubled in men 
and nearly tripled in women (Garland et al., 1992,). 
Analytic studies were performed on articles published in between 1966 to 2003 relating to 
melanoma and sunscreen use.  Odds ratios were pooled across studies by using standard meta-
analytic techniques. It was concluded however, that, no correlation was seen between melanoma 
and sunscreen use (Dennis, Freedman, & VanBeek, 2003). In between 1978-1992, cancer 
mortality rates were analyzed in Spanish provinces. The mortality rates of melanoma and other 
forms of cancer were significantly correlated with latitude. This concluded that melanoma occurs 
more frequently in northern latitudes versus lower latitude areas (Grant, 2007). 
Although sun light has been proven to have positive effects, it has limits too. There is a common 
rule that applies to everything; “too much of a good thing is bad”. There should always be a 
healthy balance between things. The recommended optimal daily intake of Vitamin D for an 
adult is approximately 1000 IU (international units). This can be achieved by spending 
approximately, depending on the day, about 15-20 minutes in the sun. Obviously, prolonged 
endurance in the sun requires one’s discretion and application of sunscreen may be necessary 
(Vitamin D, n.d.). 
Toxicity 
In healthy individuals, Vitamin D blood levels are normally found in the range of 32 to 70 ng per 
mL. Vitamin D is a fat soluble molecule, making elimination difficult. An advantage to sunlight 
obtained Vitamin D is that it is automatically regulated by a negative feedback loop. An adequate 
threshold level of Vitamin D prompts the shutdown of further synthesis. This makes overdosing 
unattainable by regulating Vitamin D levels. However, Vitamin D obtained in supplemental form 
can pose a serious threat. Toxicity results from overdosing, which is about over 1,500 
micrograms or 10,000 IU, ten times the recommended FDA daily dosage. Symptoms of 
overdosing include nausea, poor appetite, constipation, weakness, weight loss, confusion, heart 
rhythm abnormalities and Kidney stones.   
Conclusion 
The enormous positive effects of Vitamin D are vividly apparent. Its functions range from 
Calcium absorption to the suppression of tumors. A diet rich in Vitamin D is extremely 
encouraged.   On the other hand, a deprivation of Vitamin D results in a multitude of 
consequences. It is no coincidence that in recent years Vitamin D emerged in the spot light of 
research, involving the formulation of numerous exceptional works.  
Unfortunately, modern society encourages low levels of Vitamin D. People do not go out often 
and when they do are in cars. Pollution obscures some of the sun’s beneficial rays.  Furthermore, 
spending time in the sun is associated with significant sun block use. Sunlight shouldn’t be 
averted; it is a benefactor to humans. As mentioned in the Bible of Genesis, when redemption 
will arrive, G-d will use the magnificent powers of the sun to heal the righteous.     
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